Glasgow, KY – Aquablation, a new robotic surgical treatment for men with benign prostatic hyperplasia (BPH), is now available at T.J. Samson Community Hospital. BPH, or an enlarged prostate, is a common condition associated with urinary symptoms and sexual dysfunction in male patients. This new procedure produces excellent results with fewer side effects than the previous standard of care for BPH.
It is estimated that 14 million men in the U.S. suffer from BPH, where an enlarged prostate gland results in difficulty urinating, increased frequency, and urgency. The majority of men over the age of 50 will face BPH at some point in their lifetime. The condition typically impacts quality of life, and if left untreated, it increases the risk for urinary tract infections, bladder or kidney damage, bladder stones, and incontinence.
“With this enhanced view I’m able to efficiently treat the enlarged prostate and avoid injury to nearby areas,” said Dr. Mitchell Wiatrak, who is certified and highly skilled at performing this new procedure. “My patients have experienced excellent results so far.”
While medication is available to treat the condition, there are cases where medication isn’t effective or it the condition may have progressed to moderate or severe, in which case further
intervention is necessary.
The procedure is already proving to be popular with patients. “This is an exciting new treatment option for our patients,” said Neil Thornbury, CEO of T.J. Regional Health. “Dr. Wiatrak and his team are highly trained and skilled to ensure long-lasting relief and improved quality of life for their patients.”
Aquablation uses robotic technology to destroy excess prostate tissue in BPH. Unlike other procedures to treat BPH, Aquablation is guided by ultrasound to allow the surgeon to accurately see the entire prostate as they target the tissue that needs to be removed. The procedure is minimally invasive, extremely precise, and highly effective.
